Figure 3From: Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapyCorrelation between AAG and docetaxel AUC. For the 20 mg/m2 docetaxel patients that received two or more cycles, there was a correlation between the change in AAG-level and the change in docetaxel AUC0–25 between the cycles (RSQ = 0.63, p = 0.011).Back to article page